Literature DB >> 23766518

Change in β-cell mass in Japanese nondiabetic obese individuals.

Kinsei Kou1, Yoshifumi Saisho, Seiji Satoh, Taketo Yamada, Hiroshi Itoh.   

Abstract

AIM: The aim of this study was to clarify the change in β-cell mass in Japanese obese individuals.
METHODS: We obtained the pancreas at autopsy from 39 lean and 33 obese Japanese nondiabetic individuals (aged 47 ± 13 vs 47 ± 12 y, P = .83, body mass index 20.4 ± 1.6 vs 28.5 ± 3.9 kg/m(2), P < .01). Pancreatic sections were stained for insulin, and β-cell area (%BCA) was measured as the fraction of the β-cell area to the total pancreas area. β-Cell mass was then calculated as the product of %BCA and estimated pancreas weight. β-Cell replication and apoptosis were assessed by double staining for insulin and Ki67 and insulin and single-stranded DNA, respectively. The frequencies of insulin-positive duct cells and scattered β-cells were assessed as the surrogate markers of β-cell neogenesis. The α-cell area (%ACA) was also measured, and the %ACA to %BCA ratio was determined.
RESULTS: There was no increase in β-cell mass in obese individuals compared with lean individuals (0.6 ± 0.4 vs 0.7 ± 0.4 g, P = .12). β-Cell replication, β-cell neogenesis, and β-cell apoptosis were not significantly increased in the presence of obesity. There was no significant difference in %ACA to %BCA ratio between obese and lean individuals (0.91 ± 1.09 vs 0.75 ± 0.51, P = .47).
CONCLUSION: There was no increase in β-cell mass and no detectable change in β-cell turnover in Japanese obese individuals.

Entities:  

Mesh:

Year:  2013        PMID: 23766518     DOI: 10.1210/jc.2013-1373

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

Review 1.  β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.

Authors:  Yoshifumi Saisho
Journal:  World J Diabetes       Date:  2015-02-15

Review 2.  Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas.

Authors:  Yoshifumi Saisho
Journal:  Rev Diabet Stud       Date:  2016-08-10

3.  Pancreatic beta cell/islet mass and body mass index.

Authors:  Michael P Dybala; Scott K Olehnik; Jonas L Fowler; Karolina Golab; J Michael Millis; Justyna Golebiewska; Piotr Bachul; Piotr Witkowski; Manami Hara
Journal:  Islets       Date:  2019-01-22       Impact factor: 2.694

4.  GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels.

Authors:  Ayumi Kanno; Shun-Ichiro Asahara; Ayuko Furubayashi; Katsuhisa Masuda; Risa Yoshitomi; Emi Suzuki; Tomoko Takai; Maki Kimura-Koyanagi; Tomokazu Matsuda; Alberto Bartolome; Yushi Hirota; Norihide Yokoi; Yuka Inaba; Hiroshi Inoue; Michihiro Matsumoto; Kenichi Inoue; Takaya Abe; Fan-Yan Wei; Kazuhito Tomizawa; Wataru Ogawa; Susumu Seino; Masato Kasuga; Yoshiaki Kido
Journal:  JCI Insight       Date:  2020-05-07

5.  Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes.

Authors:  Hironobu Sasaki; Yoshifumi Saisho; Jun Inaishi; Yuusuke Watanabe; Tami Tsuchiya; Masayoshi Makio; Midori Sato; Masaru Nishikawa; Minoru Kitago; Taketo Yamada; Hiroshi Itoh
Journal:  Diabetologia       Date:  2021-05-03       Impact factor: 10.460

Review 6.  Life course health care and preemptive approach to non-communicable diseases.

Authors:  Hiroo Imura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

7.  Pancreatic alpha-cell mass across adult human lifespan.

Authors:  Abu Saleh Md Moin; Megan Cory; Tatyana Gurlo; Yoshifumi Saisho; Robert A Rizza; Peter C Butler; Alexandra E Butler
Journal:  Eur J Endocrinol       Date:  2020-02       Impact factor: 6.664

Review 8.  Alogliptin benzoate for management of type 2 diabetes.

Authors:  Yoshifumi Saisho
Journal:  Vasc Health Risk Manag       Date:  2015-04-10

Review 9.  Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes.

Authors:  Yoshifumi Saisho
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

Review 10.  Dynamic pathology of islet endocrine cells in type 2 diabetes: β-Cell growth, death, regeneration and their clinical implications.

Authors:  Soroku Yagihashi; Wataru Inaba; Hiroki Mizukami
Journal:  J Diabetes Investig       Date:  2015-10-15       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.